Importantly, a seminal work of Herlyn M. et al. showed that TFAM is able to induce resistance to BRAF- and MAPK- inhibitors by regulating the mitochondrial biogenesis in melanoma [41]. The gene discussed is TFAM; the disease is melanoma.